Professor Patrick Wen is a renowned neurologist specializing in neuro-oncology. He serves as the Director of the Center for Neuro-Oncology at the Dana-Farber Cancer Institute and holds a professorship at Harvard Medical School. With a distinguished career focused on brain tumor research and treatment, Prof. Wen has significantly contributed to advancing therapies for glioblastoma and other central nervous system malignancies. He is widely published and actively involved in clinical trials, aiming to improve patient outcomes. He was a key figure in the INDIGO study, which focuses on innovative treatment (Vorasienib) for brain tumors. Prof. Wen’s dedication to neuro-oncology has earned him international recognition and numerous accolades in the medical community.